SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants.

MLA

Rotondo, John Charles, et al. “SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants.” Viruses, vol. 13, no. 9, Aug. 2021. EBSCOhost, https://doi.org/10.3390/v13091687.

APA

Rotondo, J. C., Martini, F., Maritati, M., Mazziotta, C., Di Mauro, G., Lanzillotti, C., Barp, N., Gallerani, A., Tognon, M., & Contini, C. (2021). SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants. Viruses, 13(9). https://doi.org/10.3390/v13091687

Chicago

Rotondo, John Charles, Fernanda Martini, Martina Maritati, Chiara Mazziotta, Giulia Di Mauro, Carmen Lanzillotti, Nicole Barp, Altea Gallerani, Mauro Tognon, and Carlo Contini. 2021. “SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants.” Viruses 13 (9). doi:10.3390/v13091687.